Golden logoGolden logo
Advanced Search
F-Prime Capital Partners

F-Prime Capital Partners

F-Prime Capital Partners is a venture capital that is interested in biotechnology, enterprise, finance, financial services, fintech, health care, and pharmaceutical industries


F-Prime Capital is a venture capital firm in Massachusetts, United States that invests in businesses in the healthcare and technology sectors. Founded 1946 in Massachusetts, United States, this company invests in early stage, late stage venture and seed. It usually invests in Series A, Series B, Series C, Series D rounds. Its portfolio companies include Abelian Therapeutics, ABK Biomedical, Acacia Pharma, Accuri Cytometers, Adagene, Airespace, and Aclaris Therapeutics.

The firm is interested in companies that have technologies in life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. The firm is a lead investor for three investments.

F-Prime Capital is still active and as of November 2019, the company made a total of 197 investments. The company’s latest investment was on Nov 20, 2019. F-Prime Capital had 36 exits, notable of which are Precision BioSciences, ViewRay, and Kensho.


August 2, 2021
F-Prime Capital Partners raises a $64,000,000 series A round from Ayon Capital, Commerce Ventures, Diverse Angels, Kraken Ventures, Mercato Partners, Nationwide Ventures, Nevcaut Ventures, STCAP, Samsung NEXT, Seven Peaks Ventures, University Growth Fund and s20 Capital.

Funding Rounds

Invested in


Funding Rounds Participated In

Further Resources



Golden logo
By using this site, you agree to our Terms of Service.